Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways

por Zervantonakis, Ioannis K., Poskus, Matthew D., Scott, Alexis L., Selfors, Laura M., Lin, Jia-Ren, Dillon, Deborah A., Pathania, Shailja, Sorger, Peter K., Mills, Gordon B., Brugge, Joan S.
Publicado 2020